Financhill
Back

Evaxion Biotech AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
6

EVAX
Evaxion Biotech AS

Last Price:
2.57
Seasonality Move:
-49.13%
Sell
29

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.80
Seasonality Move:
35.83%
Sell
6
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy, Sell or Hold?

  • The current Evaxion Biotech AS [EVAX] share price is $2.50. The Score for EVAX is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.80. The Score for ADAP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVAX Stock Price Chart

What is Evaxion Biotech AS's stock price today?

  • The Evaxion Biotech AS share price today is $2.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing slight selling pressure.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

EVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 39.56 Sell
Chaikin Money Flow: -9582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.58 - 2.8) Sell
Bollinger Bands (100): (2.66 - 3.16) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 44.32 Sell
Chaikin Money Flow: 606950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.75 - 0.89) Sell
Bollinger Bands (100): (0.86 - 1.2) Sell

EVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.62 Sell
20-day SMA: 2.66 Sell
50-day SMA: 2.9 Sell
200-day SMA: 3.37 Sell
8-day EMA: 2.61 Sell
20-day EMA: 2.69 Sell
50-day EMA: 2.82 Sell
200-day EMA: 4.13 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.78 Buy
20-day SMA: 0.8 Sell
50-day SMA: 0.93 Sell
200-day SMA: 1.13 Sell
8-day EMA: 0.79 Buy
20-day EMA: 0.81 Sell
50-day EMA: 0.9 Sell
200-day EMA: 1.03 Sell

Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.58 per share, and an increase next year of $0.04 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.34 per share.

Evaxion Biotech AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):